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19 Abstract
20 On-farm decision support in animal health management requires a tailor-made failure 
21 costs (FC) assessment of production disorders for the individual farm. In our study we 
222 defined a generic framework to estimate the FC of production disorders in dairy cows. 
23 We converted the framework to a practical tool in which the farm-specific FC of 
24 mastitis, ketosis, lameness and metritis were estimated for 162 organic dairy farms in 
25 four European countries. Along with the structure of the framework, the FC estimation 
26 required three distinct types of model input: performance input (related to herd 
27 performance parameters), consequential input (related to the consequences of the 
28 disorders) and economic input (related to price levels). Input was derived from official 
29 herd recordings (e.g. test-day records and animal health recordings) and farmers’ 
30 responses (e.g. questionnaire replies). The average FC of mastitis, ketosis, lameness 
31 and metritis amounted to €96, €21, €43 and €10 per cow per year, respectively. The 
32 variation in FC outcomes was high among farmers and countries. Overall ranking of 
33 the disorders based on absolute values was the same for all countries, with mastitis 
34 being the costliest disorder followed in order by lameness, ketosis, and metritis. Farm 
35 specific estimates can be used to rank production related disorders in terms of their 
36 associated failure costs and thus provide valuable insights for herd health 
37 management. The practical calculation tool developed in this study should be 
38 considered by farmers or herd health advisors to support their animal health practices 
39 or advice. 
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41 Implications 
42 This study shows that empirical data can be used to estimate the on-farm economic 
43 impact of multiple production disorders. Tailor-made costs estimates can be used to 
44 rank production-related disorders in terms of their associated failure costs and thus 
45 provide valuable insights for herd health management. In general, mastitis remains the 
346 most costly production disorder on European  organic dairy farms. Nevertheless, costs 
47 estimates of other production disorders (lameness, ketosis and metritis) are 
48 considerably high and may even be more costly than mastitis on individual farms.
49 Introduction 
50 Keeping animals healthy is one of many management areas that requires attention in 
51 dairy farming. Although animal health management is deemed important by dairy 
52 farmers (Jones et al., 2016; Valeeva et al., 2007; Van Soest et al., 2015) conflicts arise 
53 when other management areas compete for the available resources of time, labour 
54 and finance. Within the animal health management area, similar conflicts also arise 
55 when farmers must decide where to allocate their restricted resources to maintain a 
56 healthy herd in the most effective way (Singer et al., 2011). This is a complex decision 
57 considering that cattle can become affected by different health disorders, with each 
58 disorder having its own characteristic symptoms and impact. The most prevalent health 
59 disorders on EU dairy farms are endemic and production related. The demand for high 
60 productivity may increase incidence levels further (Fleischer et al., 2001; Gröhn et al., 
61 1995; Vanholder et al., 2015). Common production-related health disorders (in the 
62 remainder of this manuscript presented as production disorders)  include: mastitis, 
63 ketosis, lameness and metritis which have been reported at average incidences of 
64 28%, 47%, 69% and 69%, respectively (Lam et al., 2013; Urton et al., 2005; van der 
65 Linde et al., 2010; Vanholder et al., 2015). Each of these disorders affects the overall 
66 herd performance through a decrease in production level or an increase in health 
67 treatments, labour requirements and involuntary herd removal. The costs associated 
68 with this reduced herd performance are referred to as failure costs (FC) (Hogeveen et 
69 al., 2011). The FC of mastitis, ketosis, lameness and metritis within conventional dairy 
70 farms have been reported at the range of € 87 - € 946 per case (Cha et al., 2011; 
471 Heikkilä et al., 2012; Liang et al., 2017), € 72 - € 442 per case (McArt et al., 2015; 
72 Mostert et al., 2017; Raboisson et al., 2015), € 106 - € 291 per case (Bruijnis et al., 
73 2010; Cha et al., 2010; Liang et al., 2017) and € 92 - € 230 per case( Bartlett et al., 
74 1986; Liang et al., 2017), respectively. Variations in costs estimates depended on 
75 factors such as form (clinical or subclinical), pathogen and severity. 
76 General farm performance as indicated by milk production levels and price levels (like 
77 for instance of milk and concentrate), vary greatly between countries and even 
78 between farmers within the same country. Consequently, general FC estimates are 
79 unlikely to represent the individual farm FC and are therefore unsuitable for on farm 
80 decision support. With the exception of the studies of Huijps et al. (2008) and van Soest 
81 et al. (2016), where FC estimates of mastitis were farm specific due to the use of 
82 empirical data, all other economic studies on the FC of production disorders were 
83 based on  simulation modelling (e.g., Swinkels et al., 2005; Halasa et al., 2009a; McArt 
84 et al., 2015). The simulation models within these studies represent most of the time a 
85 generic farm, assuming average settings with respect to herd size, incidence level, 
86 production level and price levels. These generic settings make a direct comparison of 
87 FC between multiple disorders almost impossible on the individual farm level. To set 
88 priorities within the animal health management area farmers require FC estimates for 
89 the various disorders in which their specific farm situation is represented and 
90 comparisons between disorders can be made. Although the economic and technical 
91 input used for economic calculations vary largely per disease the actual cost 
92 components involved of the various disorders are for the major part the same. This 
93 allows the development of a generic framework to structure and compare the economic 
94 impact for each disorder. At the same time transparency to the farmer (i.e., the decision 
595 maker) on both model in- and output should be warranted to guarantee the credibility 
96 of the estimations made. 
97 Within organic farming one of the main principles is to aim for high levels of animal 
98 health and welfare (International Federation of Organic Agriculture Movements, 2005). 
99 As such, consumers expect a higher animal health status on organic farms than on 
100 conventional ones (Hughner et al., 2007). In practice, the animal health status on 
101 organic dairy farms is, on average, not better than in the conventional sector (Hovi et 
102 al., 2003; Sundrum, 2001; Sutherland et al., 2013; van Wagenberg et al., 2017). A high 
103 animal health status in organic farming is therefore crucial to comply with consumer 
104 expectations to ensure the milk price premium organic farmers are receiving. 
105 Occurrence of one or more production disorders directly affects farm income through 
106 increased health treatments. Other, more indirect effects, are less visible considering 
107 that the associated effects are less immediate or notable to the dairy farmer, such as 
108 increased involuntary replacement or gradual milk production losses over time. For a 
109 dairy farmer it is hard to assess the economic impact for each of the different 
110 production disorders considering that multiple production disorders often occur 
111 simultaneously. Economic assessment of the current disorder status is a vital 
112 component in animal health management as the FC estimates serve as an evaluation 
113 for farmers on where and how the allocation of resources has affected farm finance 
114 and as an outlook on which production disorder may be prioritised over another. 
115 Consequently, the aim of our study was to estimate the farm specific FC of mastitis, 
116 ketosis, lameness and metritis on European organic dairy farms, by using readily 
117 available farm data, and to explore the variation in FC between and within EU countries 
118 for the different disorders.
6119 Material and methods
120 A general framework was developed to estimate the FC of production disorders in a 
121 structural approach. Following this approach, a functional tool was developed to 
122 estimate the FC of mastitis, ketosis, lameness and metritis on individual farms. In the 
123 developed tool specific attention was given to allow for individual farm characteristics 
124 on performance, disease incidence and price levels. Finally, the tool was parametrised 
125 for and applied on organic dairy farms in four European countries: France, Germany, 
126 Spain and Sweden. 
127 Framework and tool to estimate farm specific FC of production disorders
128 The framework to estimate the FC of production disorders is presented in Figure 1. To 
129 estimate the FC we were interested in the marginal effect of each production disorder 
130 on farm income. Therefore, the use of the partial budgeting technique was most 
131 appropriate. Using the partial budgeting technique, only those cost elements that were 
132 actually affected by each production disorder were included (Dijkhuizen and Morris, 
133 1997). In our study FC consisted of three main cost elements: milk production losses, 
134 treatment and herd removal. Milk production losses included the losses associated 
135 with, both, the clinical and subclinical forms of a disorder. Treatment accounted for the 
136 labour required for treatment, medication (either conventional or alternative therapy), 
137 veterinary visits and discarded milk (due to medication which requires an obligatory 
138 withdrawal period). Herd removal included the involuntary removal (slaughter) or death 
139 of an animal as a result of a disorder. Table 1 provides an overview of the evaluated 
140 production disorders, their associated case definitions and affected cost elements (milk 
141 production loss, treatment and/or herd removal) FC estimations for each disorder were 
7142 aggregated as the available empirical information lacked insights on the underlying 
143 aetiology of observed cases.  
144 Following the generic framework, a practical tool was developed in Microsoft Excel 
145 (Microsoft Corp., Redmond, WA) such that the FC of mastitis, ketosis, lameness and 
146 metritis can be estimated for an individual farm. Appendix A provides a more detailed 
147 description of the calculations performed. The FC estimations are assumed multiple 
148 exclusive, e.g. no interaction between the disorders is assumed, and FC are estimated 
149 separately for each disorder. To prevent double counting of the economic losses the 
150 FC of the different disorders cannot be summed to estimate the total economic impact 
151 of all disorders to farm income. This assumption was required because data was 
152 available on herd level only, missing the information on animals suffering from multiple 
153 disorders at the same time. For instance, one cow could attract both clinical mastitis 
154 and subclinical ketosis at the same time. In such a case the associated milk production 
155 loss is expected to be lower than the summed amount due to each disease separately. 
156 Estimated FCs can therefore only be used to compare the costs among the disorders 
157 and hence provide insight to which disorder to address management resources first. 
158 Application of the tool to assess the indicated FC costs elements requires three types 
159 of input: input on the performance of the herd, input related to the consequences of the 
160 disorder and economic input on price levels. Performance input relates to the 
161 performance of the herd and includes: the number of clinical and subclinical cases1 of 
162 a disorder, the number of dead or removed cows due to the disorder, average milk 
163 production per cow per year (kg milk per cow per year) and average milk production 
1 The number of cases reflects the number of individual animals affected by the disorder
8164 per cow per day (kg milk per cow per day). Input related to the consequences of a 
165 disorder includes: average milk production losses associated with a clinical or 
166 subclinical case (expressed as a percentage of average milk production per cow per 
167 year), withdrawal period (days), percentage of clinical cases treated with conventional 
168 or alternative therapy2, average labour requirements to treat a clinical case (hour per 
169 treated case) and percentage of clinical cases which require a veterinary visit. 
170 Economic input relates to the on-farm price levels and includes: the price of milk (€ per 
171 kg milk), feed costs (€ per kg milk), average price per conventional treatment3, average 
172 price per alternative treatment, average price of a veterinary visit, labour costs (€ per 
173 hour), average replacement costs (€ per removed or dead animal), costs of destruction 
174 (€ per dead animal) and average returns on selling an animal to the slaughter house 
175 (€ per slaughtered animal). 
176 Study population. 
177 To estimate the farm specific FC, the tool has been applied to a total of 162 EU organic 
178 dairy farms in France (n=39), Germany (n=60), Spain (n=23) and Sweden (n=40). This 
179 study was part of a larger EU funded research project, aimed to improve animal health 
180 status on organic dairy farms in the EU (IMPRO – Impact matrix analysis and cost-
181 benefit calculations to improve management practices regarding health status in 
182 organic dairy farming4). The organic dairy farms participating in this project represented 
183 the variation found in size, share and degree of settlement of organic development of 
2 Conventional therapy included: the general recommended veterinary therapy to treat the animal, may 
include the application of antibiotics if appropriate.
Alternative therapy included: any treatment generally perceived as non-conventional to treat animals 
and may include homeopathy, phytotherapy or allopathy, None of these treatments involved a 
withdrawal period for milk.
3 Average costs related to the treatment of an individual case, accounting for any retreatment costs
4 Developed tool available on http://www.impro-dairy.eu/index.php/outreach/economic-tool 
9184 organic dairy farms within Europe (Van Soest et al., 2015). More information on the 
185 selection process of the farmers and participating regions can be found in Van Soest 
186 et al. (2015), Krieger et al., (2017) and Jones et al (2017). Moreover, technical model 
187 input used in this study, differences between countries and standardisation of the 
188 various data collected has been described and discussed thoroughly in Krieger et al. 
189 (2017).
190 Parametrisation: stage 1
191 Input was derived from various data sources: herd recordings, literature and 
192 information directly obtained from the farmer. Therefore, parameterization of the tool 
193 occurred in two stages: 1) prior to the on farm application by the use of official herd 
194 recordings data and literature data and 2) during the actual on farm application by 
195 means of information directly obtained from the farmer. Official herd recordings 
196 included: treatments and disorder incidence levels, and test-day milk recordings, and 
197 was initially collected for the purpose of other research aims within the IMPRO project 
198 and described and discussed by Krieger et al. (2017) and used as primary input for 
199 this study. Data derived from the official herd recordings was only used for the 
200 performance related input. Herd recordings that could be entered directly in the tool 
201 were (stage 1 of parametrization): the number of cases of clinical mastitis and the 
202 number of dairy cows in the different lameness classes (non, moderate or severe). 
203 Lameness scores for each herd were available from the preceding farm visits and 
204 performed following the Welfare Quality® Protocol (2009) and clinical mastitis 
205 incidence was derived from herd health recordings (Krieger et al., 2017). The 
206 remaining herd recorded data needed to be processed first. The milk production data 
207 were aggregated at the farm level such that the average milk yield per cow per year 
208 was entered in the tool. Based on each test-day-date record the average number of 
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209 lactating dairy cows on the farm during the last year was estimated. For each test-day-
210 date record the distribution among lactating dairy cows in any of the following somatic 
211 cell count (SCC) categories was determined: <50, 50-100, 100-200, 200-300, 300-400 
212 and >400 x1,000 cells per ml. The average distribution among SCC classes on a farm 
213 during the last year was thereafter determined, and used as an indicator for the milk 
214 production losses associated with subclinical mastitis (Halasa et al., 2009; Huijps et 
215 al., 2008). Based on the test-day records the number of dairy cows with a fat-protein-
216 ratio (FPR) >1.5 during their first 100 days in lactation during the last year was 
217 determined. The FPR was used as an indicator for the total number of animals with 
218 subclinical ketosis on the farm (Čejna and Chládek, 2005; Duffield et al., 1997; Krogh 
219 et al., 2011). All performance related input is presented in Table 2. 
220 Technical input relating to disorder impact was derived from scientific literature, 
221 manufacturers’ norms or authors expertise (Table 3), the most recent country specific 
222 professional journals indicating price levels for each country and was cross validated 
223 by researchers from each respective country participating in this study (Table 4). Each 
224 of these parameters were administered to the tool as part of stage 1 of the 
225 parametrization. 
226 Due to the specific nature of each disorder specific changes to the framework were 
227 required for some cost components. Milk production losses associated with ketosis 
228 were estimated for cows with a disturbed FPR which was assumed to include clinical 
229 and subclinical cases of ketosis, as the provided data was on herd level. Additional 
230 milk production losses associated with farmers identified clinical ketosis cases were 
231 excluded to prevent overestimation of milk production losses associated with ketosis 
232 (Table 3). The farmers identified cases were used to calculate the economic losses of 
233 herd removal and treatment. Production loss estimates of mastitis, included both 
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234 clinical and subclinical production losses which is due to the specific nature of both 
235 disorders and moment of occurrence (Barkema et al., 1998; Suthar et al., 2013). Milk 
236 production losses associated with early metritis were assumed to be parity specific 
237 (Rajala-Schultz et al., 1999). The average replacement rate on each farm was used to 
238 determine the average distribution of dairy cows over parity 1, 2, 3 and ≥4 and the 
239 corresponding production losses. No milk production losses were assumed to be 
240 associated with late metritis. Within the FC cost calculation of  metritis losses due to 
241 subclinical forms were not accounted for due to the lack of readily available case 
242 indicator. Detection of subclinical metritis is generally done by measuring 
243 polymorphonuclear neutrophils or through ultrasonography of the uterus 
244 (Kasimanickam et al., 2004; Lenz et al., 2007), which are rather time consuming 
245 methods that require the expertise of an experienced veterinarian. Considering the 
246 specific circumstances regarding alternative treatment practices in organic farming it 
247 was assumed that 80% of all treated cows received regular veterinary recommended 
248 treatment (conventional therapy) and 25% of all treated cows received alternative 
249 treatment, if not specified otherwise by the farmer. During the farm visits, cases of 
250 clinical mastitis and clinical lameness could, when extra information on treatment was 
251 available, be further specified by the farmer using the following categories: 1) treated 
252 cases with antimicrobials 2) treated cases without antimicrobials 3) treated cases with 
253 alternative treatment or 4) untreated cases. The milk withdrawal periods were based 
254 on manufacturers’ norm for the relevant antimicrobials and organic legislation. Labour 
255 requirements to treat one case of a disorder was the amount of labour required to fully 
256 service one case of the disorder. Data derived from literature was either used for the 
257 consequential data input or to set reference price levels. 
258 Parametrisation: stage 2
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259 Data missing or not-available from either official herd recordings or literature were 
260 asked directly from the dairy farmer during the application of the tool and was part of 
261 stage 2 of tool parametrization. For this purpose, a postal questionnaire was send out 
262 preceding the farm visits. Farmers were asked to complete the questionnaire before 
263 the farm visit to facilitate the data entry during the visit. This preliminary questionnaire 
264 included questions regarding price levels, herd removal, disorder incidence levels and 
265 applied treatments. More specific, farmers were requested to indicate how many of 
266 their cows were treated for ketosis (incidence of clinical ketosis), early metritis 
267 (incidence of metritis) and late metritis (incidence of  late metritis). Furthermore, 
268 farmers were asked to indicate the number of cows culled for mastitis, lameness, 
269 ketosis and metritis, separately, and to do the same for the number of cows dead on 
270 the farm. Thereafter the total number of dairy cows that were replaced or died during 
271 last year was questioned to assess the overall average herd replacement rate. 
272 Requested economic input was the average received milk price (€ per kg milk), feed 
273 costs (including costs of roughage and concentrates, € per kg milk), labour costs (€ 
274 per hour), replacement costs (€ per replaced dairy cow), costs of destruction and 
275 collection from the farm (€ per destructed dairy cow), penalties paid last year for having 
276 a too high cell count (€ per year) and bonuses missed for having a too high cell count 
277 (€ per year). The questions relating to the economic input parameters were 
278 accompanied by country-specific reference values. The reference values were derived 
279 from professional literature and expert knowledge as indicated in Table 4. 
280 On farm tool application. The farm visits were performed by native speaking 
281 researchers. The researchers received a training on how to work with the tool and to 
282 address potential questions that may arise during the visits. Moreover, since multiple 
283 research aims were performed during each visit a visiting protocol was set up to ensure 
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284 that each farm visit proceeded in a similar manner. Furthermore the farm’s veterinarian 
285 was present to ensure validation of input data.
286 Based on the collected herd record data (Table 2) and literature data (Tables 2) and 
287 assumed price levels (Table 4) the tool was partly parametrised prior to the farm visit, 
288 stage 1 of parametrization. During the farm visits these prepared inputs were presented 
289 and discussed with the farmer. After presenting the collected herd record data, the 
290 replies on the preliminary questionnaire were collected and administered in the tool, 
291 stage 2 of parametrization. When farmers were uncertain about a value of a certain 
292 input parameter they received a more detailed explanation of the parameter’s meaning. 
293 When, thereafter, farmers were not able to derive a value the reference value (Table 
294 3) was used. Finally, FC were calculated for each individual disorder and presented to 
295 the participants. At any moment in time changes could be made to any of the inputs 
296 when any of the participants felt a value did not represent the farm specific 
297 circumstances. 
298 Statistical analysis
299 A statistical analysis was performed on the variables FC mastitis, ketosis, lameness 
300 and metritis (€ per cow per year) using SAS/ STAT® software (SAS Institute Inc., Cary, 
301 NC, USA). FC estimates are expressed in € per cow per year to correct for any effect 
302 of farm size on the outcome. Assumptions of normality of the FC was based on a 
303 graphical display of the farm-specific FC and a Shapiro-Wilk test. Depending on 
304 whether normality could be assumed, either parametric or non-parametric tests were 
305 performed. It was tested whether the FC for each disorder varied among countries. 
306 Furthermore, the relative ranking of disorders within a country was tested to determine 
307 whether the relative order varied among countries. Finally, a correlation analysis was 
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308 performed to explore how the FC of one disorder may affect in- or decrease of other 
309 FCs. 
310 Results
311 Descriptive statistics
312 Herd performance. Herd performance results are presented in Table 2. Herd size and 
313 milk production were found to be highly variable among farms with a minimum and 
314 maximum of, respectively, 7 – 395 dairy cows per farm and 3,000 – 10,634 kg milk per 
315 cow per year. The average herd size was 74 dairy cows per farm and average milk 
316 production was 6,867 kg milk per cow per year. The annual incidence was 24% for 
317 clinical mastitis and 1.2% for clinical ketosis. One farm reported no cases of clinical 
318 mastitis and 98 farms reported no cases of clinical ketosis. No distinction was made 
319 for recurring cases of any of the four disorders. One Spanish farm reported an annual 
320 incidence of clinical mastitis of 108%, suggesting recurrent cases, although this was 
321 not scrutinized. For 28 out of the 39 French farms only bulk tank SCC, average 308 (x 
322 1,000 cells/mL), was available. To determine the distribution of dairy cows in the 
323 various SCC classes, a distribution suggested by Huijps et al. (2008) was used to 
324 determine annual incidence in the various SCC classes. The remaining 11 out of 39 
325 French farms reported SCC distributions similar to the other countries. The average 
326 distribution of SCC for the German, Spanish and Swedish farms was 26%, 22%, 20, 
327 9%, 6% and 16% for the respective SCC classes, <50, 50-100, 100-200, 200-300, 300-
328 400 and >400 (x 1,000 cells/mL). The average annual incidence of subclinical ketosis 
329 was 19%. On 6 farms no cases of subclinical ketosis were reported out of which 5 
330 farms also reported no cases of clinical ketosis. On average, 80% of all animals were 
331 found non-lame, 14% moderately lame and 6% severely lame. On 2 farms all dairy 
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332 cows were detected lame and on 12 farms no lame cows were reported. For early and 
333 late metritis, 58 farms indicated no occurrence of one of these disorders. Out of these, 
334 on 35 farms both early and late metritis did not occur. 
335 Average replacement rate was 0.23 with a minimum of 0.01 and maximum of 0.59. 
336 The relatively low reported replacement rate on some farms may be an indication of 
337 the farmers’ intention to increase herd size in the coming years. Total herd removal 
338 rate as a result of one of the four disorders was 10%, however, a total of 15 farms 
339 reported total herd removal rates larger than the replacement rate suggesting that 
340 some cows were removed due to a combination of disorders. This was not further 
341 scrutinized.
342 Consequences of a disorder. With the exception of one change made by a German 
343 farmer, no changes were made to the input related to the consequences of a disorder. 
344 The change made by the German farmer was to the withdrawal period of mastitis 
345 treatment, which was extended from 6 days to 12 days.
346 Economic descriptives. Most farmers indicated price levels other than the provided 
347 reference values. An overview of the percentage of farmers that actually changed the 
348 reference value and the resulting assessed average price levels is provided in Table 
349 4. Reasons for changing the reference value were not asked to the farmers. No 
350 Spanish farmer indicated that he had to pay additional penalties or missed any 
351 bonuses due to an elevated SCC. In contrast, 5%, 46% and 55% of the German, 
352 French and Swedish farmers indicated they had to pay penalties during the last year 
353 due to an elevated SCC of, on average, € 637, €1,434 and € 527, respectively. From 
354 the participating dairy farmers, 10%, 10% and 75% of the German, French and 
355 Swedish farmers missed a bonus due to an increased SCC of, on average, at a cost 
16
356 of € 555, € 1,121 and € 2,168, respectively. Such changes may be depend on local 
357 regulation or contracts with various dairy companies to which the milk was delivered.
358 Failure costs
359 Failure costs for all of the four disorders, and their respective cost components, are 
360 presented in Table 5. The total FC for mastitis were on average € 106, € 145, € 138 
361 and € 124 per cow present per year for the German, Spanish, French and Swedish 
362 farmers, respectively. The lowest FC on an individual farm were equal to € 32 per cow 
363 per year and the highest reported FC were € 462 per cow per year, both on French 
364 farms. Overall, the largest contributors to the total FC of mastitis were milk production 
365 losses, both due to clinical and subclinical mastitis, and herd removal losses. On one 
366 French and one Swedish farm, negative removal costs were reported, suggesting an 
367 economic benefit following herd removal, which is theoretical possible when slaughter 
368 value exceeds the costs of replacement. The total FC for ketosis were on average € 
369 28, € 4, € 11 and € 29 per cow present per year for the German, Spanish, French and 
370 Swedish farmers, respectively. The highest reported FC of ketosis were reported on a 
371 German farm, € 135 per cow per year, and the lowest FC were reported on both one 
372 Spanish and one French farm, € 0 per cow per year, following no reported cases of 
373 ketosis. The largest contributor to the total FC of ketosis was milk production losses. 
374 Nevertheless, on 4 farms the costs of herd removal exceeded the milk production 
375 losses. The total FC for lameness were on average € 48, € 31, € 53 and € 33 per cow 
376 per year for the German, Spanish, French and Swedish farmers, respectively. The 
377 highest reported FC of lameness were reported on a French farm, € 269 per cow per 
378 year, and lowest FC were negative and reported on a Swedish farm, - € 6 per cow per 
379 year. On the latter farm, losses were compensated by negative herd removal costs 
380 which were a consequence of revenues made from slaughter, which were higher than 
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381 the total costs of replacement and destruction. The highest and lowest FC, €269 and -
382 €1 per cow per year, associated with lameness were found among French farmers. 
383 The total FC for metritis were on average € 21, € 5, € 4 and € 4 per cow per year for 
384 the German, Spanish, French and Swedish farmers, respectively. The highest FC were 
385 reported on a German farm, € 96 per cow per year, and the lowest reported costs were 
386 € 0 per cow per year and reported in each country. Milk production losses due to 
387 metritis, contrary to the other disorders, contributed only marginally to the total FC, 
388 whereas herd removal and discarding milk, following antimicrobial therapy, contributed 
389 the most. 
390 A test for normality on the variables FC of mastitis, ketosis, lameness and metritis, 
391 expressed in € per cow per year, was performed and could not prove a normal 
392 distribution of the data. Therefore all relevant tests were performed using non-
393 parametric tests. An overview of the variation in FC for each disorder is presented in 
394 Figure 2 including any significant differences among countries, using a Kruskal-Wallis 
395 test. The FC of mastitis were found significantly higher on Spanish farms compared to 
396 German farms (P<0.001). The FC of ketosis were found lowest on Spanish farms 
397 (P<0.01) and both German and Swedish farms (P<0.001) had higher FC of ketosis 
398 compared to French farms. The FC of lameness were higher on German and French 
399 farms compared to the Spanish farms, respectively P=0.03 and P=0.02. The FC of 
400 metritis were found highest on German farms compared to the other three countries 
401 P≤0.001.
402 Although the magnitude of FC for the four disorders varied among countries a Kruskal-
403 Wallis test on the relative ranking on the individual farm of the four disorders by their 
404 FC estimates indicated that, for all countries, mastitis was the disorder with the highest 
405 FC, followed by lameness, ketosis and metritis. Two exemptions existed; in Spain no 
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406 significant difference was found between rank three and four which were ketosis and 
407 metritis and in Sweden no significant difference was found between rank two and three 
408 which were ketosis and lameness. 
409 Spearman’s rank correlation coefficient test revealed a positive and significant 
410 correlation coefficient between the FC of metritis and the FC of ketosis (rs = 0.21, P = 
411 0.007) and between the FC of metritis and the FC of lameness (rs = 0.28, P < 0.001). 
412 Meaning that a subsequent increase of these variables may lead to an increase in the 
413 correlated variable, and/or vice-versa. However, based on the correlation test no 
414 causality can be assumed on which variables influences the other variable.
415 Discussion
416 Our study estimated the farm specific FC of four common production disorders, 
417 mastitis, ketosis, lameness and metritis on European organic dairy farms. FC 
418 estimations of production disorders on organic dairy farms have not been estimated 
419 previously. Moreover, the method used in this study estimates the FC of multiple 
420 disorders by setting up a framework which makes it possible to make on-farm 
421 comparisons on the economic impact of the disorders. A large variation in FC estimates 
422 both among and within the studied countries is reported. This variation is provoked by 
423 the differences in disease incidence levels and by the variation in herd price levels. 
424 The use of average technical input values to represent production losses, treatments 
425 and culling rates acts as a limitation in that respect, resulting in an underestimation of 
426 the actual herd variance. However, the aim of this study was to estimate the farm 
427 specific failure costs by using readily available farm data, which justified the 
428 assumption on average technical input parameters.
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429 For the parameterisation of technical input values insights from studies based on data 
430 from conventional farms were used. Biological herds, however, may have different 
431 breeds and consequently have different herd milk production levels than conventional 
432 herds. To account for this breed aspect production losses were defined as a relative 
433 decrease in average herd production level. Meaning that low production herds had 
434 lower absolute milk production losses that high yielding farm, reflecting the current 
435 believe that production losses are higher in high yielding herds.
436 The herd removal behaviour of the farmers regarding the various production disorders 
437 was not recorded which could have led to an overestimation of the failure costs in 
438 cases were affected animals were immediately removed upon diagnosis, to prevent 
439 the occurrence of production losses and treatment costs. Such a situation can be 
440 attractive to the farmer when rearing costs are low, slaughter values are high and/or a 
441 low milk price is received. Occurrences of these conditions as experienced on some of 
442 the evaluated farms reflect a high economic opportunity for such an early cull strategy, 
443 provided that a replacement heifer is available directly after the herd removal of the 
444 affected cow. These situations should be accounted for in future costs estimations 
445 when individual follow-up data would be available. 
446 A comparison of the incidence levels found in our study compared to a large set-up 
447 study on the incidence levels of multiple postpartum disorders in conventional herds in 
448 10 EU countries found similar variations in incidence levels regarding mastitis, ketosis, 
449 lameness and metritis (Suthar et al., 2013). The average incidence levels in that study 
450 tended to be lower than the incidence levels reported in our study. Nevertheless, other 
451 studies reported incidence levels in organic systems to be comparable to incidence 
452 levels found in conventional systems (Hovi et al., 2003; Sutherland et al., 2013; van 
453 Wagenberg et al., 2017). 
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454 Health disorder information in our study was partly derived from official recordings and 
455 partly reported by farmers. There is a potential bias in using farmers reports of the 
456 incidences of the different disorders which may over- or underestimate the true 
457 incidence levels (Bartlett et al., 2001; Richert et al., 2013; Richert et al., 2013). In our 
458 study, the incidence of a large proportion of production disorders was established, 
459 based on test-day milk records such as: subclinical mastitis via SCC (Halasa et al., 
460 2007) and subclinical ketosis via FPR during the first 100 days in milk (Duffield et al., 
461 1997; Čejna and Chládek (2005); Krogh et al. (2011)), or via an assessment made 
462 following a protocol, such as the Welfare Quality® assessment protocol for cattle.  In 
463 our study the farmer’s veterinarian was present to confirm incidence levels of the 
464 various production disorders to prevent reporting bias by the farmer. Input variables 
465 derived from official recordings could also be disputed. For example, in this study a cut 
466 off value of >1.5 during the first 100 DIM was used as introduced by Čejna and Chládek 
467 (2005) and evaluated by Krogh et al. (2011) as an effective herd level indicator 
468 although limited by sensitivity (0.63) and specificity (0.79). Meaning that our study 
469 should (with generally low prevalence levels) yield many more false positives than false 
470 negatives. The FPR is thus expected to overestimate the true prevalence. A 
471 comparison with prevalence studies performed in the EU, however, e.g. van der Drift 
472 et al., (2012) or Berge and Vertenten (2014) seems to confirm that our study may be 
473 underestimating rather than overestimating SCK prevalence. Moreover, the 
474 aforementioned studies used cows-sides test generally recognized as having a higher 
475 accuracy (keto-test and BHBA blood levels). The general believe is that herd with a 
476 lower milk production level have less cases of ketosis (Vanholder et al., 2015). The 
477 general lower production levels and different breeds used may lead to lower levels of 
478 SCK in organic dairy farms. Based on the aforementioned reasons and the rationalism 
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479 method and face validity (Sørensen, 1990) we decided that FPR results were an 
480 appropriate indicator for SCK in this study.It should be noted that better indicators may 
481 become present over time e.g. routinely collected claw health data derived from claw 
482 trimmers recordings or BHBA levels in milk, urine or blood from dairy cows as an 
483 indicator for subclinical ketosis. At the moment these data were not routinely collected.
484 Furthermore, the availability of information among countries differs and may be more 
485 evolved, such as the use of Bulk tank SCC vs. individual reports on SCC. To omit 
486 reporting bias, the current farm information systems should adapt to include more 
487 routinely collected animal health related data, e.g. as part of new developed precision 
488 livestock farming technologies (Rutten et al., 2013), which may subsequently lead to 
489 more accurate FC estimates. Recent simulation model studies on the FC of ketosis 
490 reported values of  $289 or $203 per case of subclinical ketosis (Gohary et al., 2016; 
491 McArt et al., 2015). Conversion of these costs factors using the incidence of subclinical 
492 ketosis from our study results in slightly higher FC estimations per unit of cow present. 
493 This could be a consequence of the fact that the other studies included additional cost 
494 factors which were not included in our study, such as: displaced abomasum, metritis 
495 and reduction in reproductive performance. Bruijnis et al. (2010) reported FC of 
496 lameness to average $75 per cow per year and Cha et al. (2010) reported FC of $120 
497 to $216 per case depending on the type of lesion. The lower reported costs of 
498 lameness in our study may be a consequence of the relatively good hoof health status 
499 on the organic dairy farms included in our study. Recent estimates on the FC of metritis 
500 reported values of $171 to $262 per case under US conditions (Liang et al., 2017) 
501 which exceeds our own estimates. The study performed by Liang et al. included 
502 increased costs caused by secondary disorders (e.g. ketosis, mastitis). Metritis 
503 incidence in our study was reported by the farmer only and could not rely on any official 
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504 recorded data. Similar levels of variation in FC of mastitis and a slightly higher average 
505 reported FC of mastitis were found in van Soest et al. (2016) in which also farm specific 
506 FC of mastitis were estimated for conventional Dutch dairy farms using a more 
507 systematic and precise data collection. The variation in FC estimates, found in our 
508 study, was larger than those found in the other studies. It could be stated that the 
509 average farm specific FC estimated in our study are at least comparable to those 
510 obtained by more complex estimation methods. At the same time our farm-specific FC 
511 estimates give a better representation of the actual variation among farms. The merit 
512 in our study thus lies in the fact that the FC estimates are farm specific whereas 
513 economic simulation models reflect only average farm situations. In practice this 
514 provides a transparent tool for farmers to explore their FC by using readily available 
515 farm information. Contrary to model studies, the variation within disorders (e.g. various 
516 pathogens may cause mastitis in various forms and severity) however, was not taken 
517 into account. FC estimations for each disorder were generalized as the available 
518 information lacked insights on the underlying aetiology. The value in such calculation 
519 lie in the fact that the outcomes serve as a warning mechanism to indicate the need 
520 for further exploration to define the exact cause and determine the most relevant 
521 treatment options.
522 Subclinical ketosis has been found to be associated with increased odds of developing 
523 metritis, clinical ketosis and displaced abomasum (Suthar et al., 2013). Correa et al. 
524 (1993) reveals a causal relation of ketosis on metritis. Metritis occurrence was 
525 however, also affected by other events such as stillbirth, dystocia and retained 
526 placenta factors not taken into account in this study. The latter effects have also been 
527 reported more recently by Potter et al. (2010). None of these mentioned interactions 
528 were reported by Heuer et al. (2001). These findings may provide a technical 
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529 explanation on the found positive correlation between FC of ketosis and metritis in our 
530 study. Nevertheless, no technical explanation can be given on a correlation between 
531 metritis and lameness found in our study, whereas a technical explanation of a 
532 correlation between mastitis and ketosis (Raboisson et al., 2014) and lameness and 
533 ketosis (Heuer et al., 2001) can be given based on literature. This would suggest that 
534 a technical explanation on itself is insufficient to explain the correlation and other 
535 potential factors which may play an important role such as: stockmanship and housing 
536 conditions. The suggestion of reducing the FC of one disorder and thereby benefiting 
537 in the reduction of the FC of other disorders (McArt et al., 2015), based on the findings 
538 in our study, may in practice not hold for all disorders. Future FC estimations should, 
539 therefore be cautious in including such effects. 
540 A first step towards a more farm specific FC estimate was made by Huijps et al. (2008) 
541 on the costs of mastitis. In that study a comparison was made between the perceived 
542 FC - as derived from the incidence and price levels as indicated by the farmer - and 
543 the reference FC as defined by the authors. A distinction was made between farmers 
544 overestimating and underestimating the FC, suggesting that the farmers’ perceived 
545 values were inferior to the authors’ base line values. In our study, this assumption was 
546 the other way around. Input provided by the farmer was assumed superior to the 
547 provided reference values. Reference values were only used when the farmer was 
548 unable to derive own input values. This assumption relates to the farm-centred 
549 approach in which farmer and veterinarian are acknowledged as a trusted resource 
550 and are actively involved in the decision making process which is hypothesized to have 
551 a positive effect on the adoption of new measures (Duval et al., 2016; Jones et al., 
552 2017, 2016). Farm-centred FC estimations, such as carried out using the tool 
553 developed for this study, have merit during the on-farm decision making process as 
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554 they are adaptable to the individual farm circumstances and less time-consuming than 
555 simulation models (Cannas da Silva et al., 2006). Although not further scrutinized, 
556 farmers may feel that the FC estimations reflect their farming situation, providing the 
557 farmer with better insights in the economic situation of animal health on their farm, 
558 provided that farmers are able to detect and report each case of a disorder or 
559 veterinarians are involved in validation of the farm health data input. The tailored FC 
560 estimation method used in our study could be used to strengthen the farm advice 
561 provided by e.g. the veterinarian. The acceptance and potential possibilities for future 
562 application of on-farm calculation tools should therefore be the focus of new studies.
563 Conclusion
564 This study is the first to explore on-farm FC of four common production disorders on 
565 EU organic dairy farms. Using a structured method enabled a comparison of FC 
566 estimates on the individual farm for multiple production disorders. Generally, the FC of 
567 mastitis were found highest, followed by the FC of ketosis, lameness and metritis. The 
568 variation in FC outcomes was highly variable among farmers, indicating the need for 
569 farm specific estimations when advising farmers in their animal health management. It 
570 is believed that the farm-centred approach used in this study will aid the on-farm 
571 decision support in animal health.
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807 Table 1 . Overview of evaluated categories of production disorders,their associated case definition, origin of the data source to determine incidence levels and cost elements 
808 affected by the disorder . 
Production disorder Case definition Data source used in 
incidence estimation
Costs element(s) affected 
(see Figure 1)
Mastitis
  Clinical mastitis Gross abnormalities in secreted milk (e.g. discoloration, clots, flakes and pus) and/or 
physical abnormalities of the udder: acute, diffuse swelling and warmth, pain and 
gangrene in severe cases, chronic local fibrosis and atrophy (Radostits et al., 2007).
Farm recordings Milk production loss, 
treatment, herd removal
  Subclinical mastitis Diagnosed based on individual somatic cell count or based on bulk tank somatic cell 
count (Huijps et al., 2008; Halasa et al.,  2009).
Milk records Milk production loss
Ketosis
  Clinical ketosis Cattle show wasting with decreased appetite, fall in body condition and milk 
production where some cows have short periods of bizarre neurological and 
behavioural abnormality (Radostits et al., 2007).
Farm recordings Milk production loss, 
treatment labour, herd 
removal
  Subclinical ketosis Measured as a disturbed fat: protein ratio (FPR >1.5) in the milk during the first 100 
days in milk ( Duffield et al. 1997;, Čejna and Chládek, 2005).
Milk records Milk production loss
Lameness
  Moderate lameness Measured in moving animals, defined as imperfect temporal rhythm in stride creating 
a limp (Welfare Quality®, 2009).
Welfare Quality® 
assessment protocol on-
farm assessment
Milk production loss, 
treatment, herd removal
  Severe lameness Measured in moving animals, defined as strong reluctance to bear weight on one 
limb, or more than one limb affected (Welfare Quality®, 2009).
Welfare Quality® 
assessment protocol on-
farm assessment
Milk production loss, 
treatment, herd removal
Metritis
  Early metritis Only clinical forms reported1, occurs within 21 days postpartum and is characterized 
by an enlarged uterus and a watery red-brown fluid to viscous off-white purulent 
discharge, which often has a fetid odour (Sheldon et al., 2009).
Farm recordings Treatment, herd removal
  Late metritis Only clinical forms reported1, clinical late metritis is defined as the presence of a 
purulent uterine discharge detectable in the vagina 21 days or more postpartum or 
mucopurulent discharge detectable in the vagina after 26 days postpartum (Sheldon 
et al., 2009).
Farm recordings Milk production loss, 
treatment, herd removal
809 1 Detection of subclinical metritis is typically done by measuring polymorphonuclear neutrophils exceeding a predefined threshold value or through ultrasonography of the uterus 
810 (Kasimanickam et al., 2004; Lenz et al., 2007). Both methods are time consuming and require the  expertise of an experienced veterinarian.
811
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812 Table 2 Technical input parameters, derived from test-day records, herd health recordings or via a questionnaire responses of the farmer, indicated by mean values reported per 
813 country (respective minimum; maximum reported values in parentheses).
Parameter DE (n=60) ES (n=23) FR (n=39) SE (n=40)
Dairy cows (n/yr) 76 (19; 314) 59 (13; 392) 63 (7; 135) 91 (29; 395)
Milk production (kg/cow/yr) 6,577 (3,420; 9,828) 6,301 (3,000; 8,500) 5,522 (3,193; 8,108) 8,939 (5,912; 10,634)
Clinical mastitis (%) 21 (3; 75) 40 (19; 85) 33 (2; 1081) 10 (0; 27)
Clinical ketosis (%) 1 (0; 11) 1 (0; 10) 0 (0; 4) 2 (0; 12)
FPR >1.5 first 100 DIM (%) 30 (6; 72) 4 (0; 18) 11 (0; 34) 20 (6; 35)
Metritis (%) 8 (0; 40) 4 (0; 15) 2 (0; 14) 2 (0; 12)
Endometritis (%) 4 (0; 20) 3 (0; 14) 4 (0; 46) 3 (0; 14)
Lameness scoring
  Not lame (%) 75 (10; 100) 88 (73; 100) 71 (0; 100) 94 (75; 100)
  Moderate (%) 15 (0; 44) 10 (0; 27) 22 (0; 57) 5 (0; 24)
  Severe (%) 10 (0; 77) 0 (0; 3) 7 (0; 84) 1 (0; 9)
SCC classes (%)1
  <50 22 (5; 52) 23 (7; 41) 22 (0; 50) 37 (21; 63)
  50-100 25 (15; 42) 17 (7; 31) 21 (0; 33) 21 (13; 27)
  100-200 24 (13; 33) 20 (8; 33) 18 (3; 27) 18 (12; 24)
  200-300 10 (3; 15) 10 (5; 19) 10 (7; 14) 7 (2; 11)
  300-400 5 (1; 11) 6 (3; 11) 11 (2; 23) 4 (1; 9)
  >400 13 (3; 29) 23 (9; 47) 20 (0; 66) 13 (4; 26)
Bulk tank somatic cell count (x1,000 cells/ml) NA3 NA3 308 (155; 507) NA3
Annual replacement rate (%) 19 (1; 48) 17 (4; 36) 24 (3; 39) 31 (10; 59)
Culled cows 
  Mastitis (n/yr) 6 (0; 25) 3 (0; 21) 5 (0; 29) 10 (0; 25)
  Ketosis (n/yr) 0 (0; 12) 0 (0; 0) 0 (0; 0) 0 (0; 1)
  Lameness (n/yr) 3 (0; 13) 1 (0; 7) 2 (0; 9) 2 (0; 12)
  Metritis (n/yr) 2 (0; 16) 0 (0; 0) 0 (0; 4) 0 (0; 3)
Died cows 
  Mastitis (n/yr) 0 (0; 3) 0 (0; 5) 0 (0; 2) 1 (0; 14)
  Ketosis (n/yr) 0 (0; 0) 0 (0; 0) 0 (0; 2) 0 (0; 3)
  Lameness (n/yr) 0 (0; 5) 0 (0; 3) 0 (0; 6) 1 (0; 4)
  Metritis (n/yr) 0 (0; 2) 0 (0; 0) 0 (0; 0) 0 (0; 1)
814 1 Value larger than 100 suggesting recurring cases of clinical mastitis 
815 2 Differences not equal to 100 due to rounding  
816 3 NA = Not applicable
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817 Table 3 Default technical input parameters related to the consequences of a disorder, derived from literature, 
818 experts’ knowledge, authors’ expertise or manufacturers’ norm,.
Description Value Reference
Milk production losses (% of 305d milk production)
  Clinical mastitis 5 Seegers et al. (2003), McDougall et al. (2009)
  SCC classes Huijps et al. (2008)
    <50 0
    50-100 0.5
    100-200 1.75
    200-300 2.65
    300-400 3.25
    >400 8
  Ketosis
    FPR1 >1.5 first 100 DIM 5 Bareille et al. (2003)
  Lameness classes
Green et al. (2002), Bicalho et al. (2008) and 
Bruijnis et al. (2010) 
    Non 0
    Moderate 3
    Severe 8
  Early metritis parity classes Rajala and Gröhn (1998)
    P1 0.28
    P2 0.26
    P3 0.84
    P4+ 0.54
  Late metritis 0
Milk withdrawal period antimicrobials (days)
  Mastitis 6 Manufacturers’ norm
  Ketosis NA2
  Lameness 7 Manufacturers’ norm
  Early metritis 5 Manufacturers’ norm
  Late metritis NA2
Labour requirements (min / treatment / clinical case)
  Mastitis 45 Huijps et al. (2008), van Soest et al. (2016)
  Ketosis 20 Experts’ knowledge and authors’ expertise
  Lameness 70 Bruijnis et al. (2010)
  Early metritis 30 Experts’ knowledge and authors’ expertise
  Late metritis 15 Experts’ knowledge and authors’ expertise
819 1 FPR = Fat / Protein ratio
820 2 NA = Not applicable
821
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822 Table 4 Economic input parameters reference values, percentage of dairy farmers that made a change in the 
823 reference value and the resulting range of adjusted values for DE (n=60), ES (n=21), FR (n=39) and SE (n=40).
Variable Country Reference 
value
Farmers adjusting 
reference value
Mean adjusted values  
(min; max)
Milk price (€/kg milk)
DE 0.41 95% 0.45 (0.37; 0.55)
ES 0.40 78% 0.47 (0.40; 1.00)
FR 0.41 74% 0.44 (0.37; 1.00)
SE 0.36 93% 0.45 (0.40; 0.52)
Feed price (€/kg milk)
DE 0.15 92% 0.20 (0.07; 0.34)
ES 0.14 61% 0.17 (0.12; 0.40)
FR 0.11 56% 0.10 (0.03; 0.15)
SE 0.13 58% 0.17 (0.12; 0.29)
Labour (€/hr)
DE 20 52% 17 (5; 25)
ES 20 52% 15 (3; 20)
FR 20 41% 19 (5; 50)
SE 21 53% 22 (11; 50)
Replacement value dairy cow (€/cow)
DE 1,300 78% 1,402 (900; 1,800)
ES 1,500 43% 1,535 (1,000; 2,200)
FR 1,400 41% 1,351 (900; 1,800)
SE 1,070 100% 1,217 (792; 1,650)
Destruction costs dairy cow (€/cow)
DE 170 53% 114 (5; 200)
ES 170 61% 110 (2; 230)
FR 170 28% 149 (37; 200)
SE 152 100% 164 (131; 902)
Slaughter price dairy cow (€/cow)
DE 555 98% 842 (110; 1,433)
ES 555 74% 492 (250; 700)
FR 555 72% 838 (150; 1,238)
SE 495 100% 807 (344; 1,127)
Penalties paid (€/yr)1
DE - 5% 637 (50; 1,000)
ES - - -
FR - 46% 1,434 (302; 4,642)
SE - 55% 527 (26; 2,258)
Bonuses missed (€/yr)2
DE - 10% 555 (50; 1,617)
ES - - - (-; -)
FR - 10% 1,121 (616; 1,616)
SE - 75% 2,168 (-; 6,732)
824 1 Penalties paid last year for having a too high cell count (€ per year) 
825 2 Bonuses missed for having a too high cell count during the last year (€ per year)
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826 Table 5 Failure costs (FC) estimation for the four disorders (mastitis, ketosis, lameness and (endo)metritis) and the 
827 respective disorder costs factors for each of the 4 different countries Germany (DE), Spain (ES), France (FR) and 
828 Sweden, expressed in € per cow per year (minimum; maximum in parentheses).
DE (n=60) ES (n=23) FR (n=39) SE1 (n=40)
Mastitis
  Subclinical production losses 17 (2; 55) 37 (20; 74) 31 (2; 95) 13 (0; 37)
  Clinical milk production losses 33 (12; 55) 51 (28; 90) 50 (15; 317) 43 (20; 84)
  Discarded milk 11 (0; 32) 15 (0; 51) 17 (0; 65) 9 (0; 31)
  Veterinary treatment 0.2 (0; 0.8) 0.4 (0.2; 0.9) 0.4 (0; 1.2) 0.4 (0; 0.9)
  Medication 4 (0; 16) 5 (0; 15) 6 (0; 25) 4 (0; 12)
  Homeopathic therapy 2 (0; 19) 4 (0; 30) 1 (0; 7) 0 (0; 0)
  Labour 3 (0.3; 11) 4 (0.9; 11) 5 (0.3; 16) 2 (0; 5)
  Herd removal 37 (0; 211) 29 (0; 205) 27 (-42; 314) 52 (-192; 259)
  Total subclinical mastitis 33 (12; 55) 51 (28; 90) 50 (15; 317) 43 (20; 84)
  Total clinical mastitis 73 (13; 316) 94 (43; 246) 87 (6; 335) 81 (9; 319)
  Total FC mastitis 106 (36; 349) 145 (79; 294) 138 (32; 462) 124 (45; 361)
Ketosis
  Milk production losses 24 (7; 57) 3 (0; 16) 10 (0; 38) 25 (6; 47)
  Discarded milk 0.0 (0; 0) 0 (0; 0) 0 (0; 0) 0 (0; 0)
  Veterinary treatment 0.3 (0; 3) 0.3 (0; 2.4) 0.1 (0; 1) 0.8 (0; 5)
  Medication 0.3 (0; 3) 0.3 (0; 2.4) 0.1 (0; 1) 0.3 (0; 2)
  Homeopathic therapy 0.2 (0; 1) 0.1 (0; 1) 0 (0; 0.5) 0.3 (0; 2)
  Labour 0.3 (0; 2) 0.3 (0; 2) 0.1 (0; 0.9) 0.5 (0; 3)
  Herd removal 3 (0; 93) 0 (0; 0) 0.6 (0; 22) 2 (0; 49)
  Total FC ketosis 28 (7; 135) 4 (0; 16) 11 (0; 41) 29 (10; 77)
Lameness
  Milk production losses 21 (0; 139) 7 (0; 16) 22 (0; 143) 6 (0; 28)
  Discarded milk 5 (0; 65) 7 (0; 21) 14 (0; 62) 6 (0; 25)
  Veterinary treatment 0.4 (0; 3.1) 0 (0; 0.1) 0.3 (0; 3) 0 (0; 0.2)
  Medication 0.6 (0; 2) 0.2 (0; 0.7) 0.6 (0; 2) 1 (0; 5)
  Homeopathic therapy 0.8 (0; 12) 0.6 (0; 2) 2 (0; 6) 0 (0; 0)
  Labour 0.6 (0; 5.1) 0 (0.1; 0.4) 0.4 (0; 6) 0.1 (0; 0.7)
  Herd removal 20 (0; 169) 16 (0; 107) 14 (-1.52; 92) 20 (-62; 84)
  Total FC lameness 48 (0; 257) 31 (0; 121) 53 (-1.42; 269) 33 (-62; 102)
Metritis
  Milk production losses 0.5 (0; 3) 0.3 (0; 1) 0.2 (0; 2) 0.2 (0; 1)
  Discarded milk 6 (0; 23) 3 (0; 12) 1 (0; 11) 2 (0; 14)
  Veterinary treatment 0.1 (0; 0.4) 0 (0; 0.2) 0 (0; 0.1) 0 (0; 0.1)
  Medication 0.8 (0; 4) 0.4 (0; 2) 0.2 (0; 1) 0.2 (0; 1)
  Homeopathic therapy 0.4 (0; 2) 0.2 (0; 0.8) 0.1 (0; 0.7) 0.1 (0; 0.6)
  Labour 0.9 (0; 5) 0.4 (0; 2) 0.5 (0; 9) 0.4 (0; 2)
  Herd removal 13 (-12; 84) 0 (0; 0) 2 (0; 23) 0.9 (0; 17)
  Total FC metritis 21 (0; 96) 5 (0; 16) 4 (0; 45) 4 (0; 21)
829 1 Costs estimations under Swedish circumstances were made in Swedish Krona (SEK) and converted to Euro in 
830 which 1SEK=€0.11 
831 2 Negative values for herd removal occur when revenues from cow sales are higher than costs of rearing new 
832 heifer for replacement, thus representing a benefit.
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850 Figure 1 Overview of the generic framework to estimate the FC of production-related disorders on the farm level 
851 consisting of the three main cost categories: milk production loss, treatment and herd removal. Model input requires 
852 performance input (squares), consequential input (squares within squares) and economic input (rounds). 
853 Figure 2a,b,c,d Boxplots for failure costs (€ per cow per year) of mastitis (a), ketosis (b), lameness (c) and metritis (d) 
854 for the four different countries. Significant differences between countries for each disorder are given, different letters 
855 indicates a significant difference at P < 0.05, following a non-parametric Kruskal-Wallis test. 
Appendix I Costs calculations for individual disorders
Mastitis
Costs are presented on herd level in €/farm/yr, for an evaluation of average costs per dairy cow 
results need to be divided by the number of dairy cows on the farm (Ncows)
Costs of milk production loss subclinical mastitis:
𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝑀 = [𝐹𝑆𝐶𝐶50 × 𝑁𝑐𝑜𝑤𝑠 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐶50 + 𝐹𝑆𝐶𝐶100 × 𝑁𝑐𝑜𝑤𝑠 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠
𝑠𝑆𝐶𝐶100 + 𝐹𝑆𝐶𝐶200 × 𝑁𝑐𝑜𝑤𝑠 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐶200 +  𝐹𝑆𝐶𝐶300 × 𝑁𝑐𝑜𝑤𝑠 × 𝑀𝑃𝑦𝑟× 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐶300 + 𝐹𝑆𝐶𝐶400 × 𝑁𝑐𝑜𝑤𝑠 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐶400 +  𝐹𝑆𝐶𝐶 > 400 × 𝑁𝑐𝑜𝑤𝑠× 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐶 > 400] × [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
In which F is the fraction of dairy cows in the specific class, (SCC0-50, SCC50-100, SCC100-
200,…SCC>400). Ncows is the number of dairy cows on the farm, MPyr is the average milk production 
per cow per year (kg/cow/yr), PMPlossSCC is the percentage reduction in milk production for each 
respective SCC class, and Pmilk and Pfeed are the price of milk (€/kg milk) and feed (€/kg milk)
Costs of milk production loss clinical mastitis:
 𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝑀 = [𝑁𝐶𝑀 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝑀] × [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
In which NCM is the number of cows with clinical mastitis (cases per yr) and PMPlossCM is the 
percentage reduction in milk production for each case of clinical mastitis
Costs of medication
𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐶𝑀 = [𝑁𝐶𝑀𝐴𝐵 + 𝑁𝐶𝑀𝑁𝐴𝐵] × 𝑃𝑚𝑒𝑑𝐶𝑀
In which NCMAB is the number of cows with CM treated with antibiotics NCMAB is the number of cows 
with CM treated without antibiotics and PmedCM is the price of medication.
Costs of veterinary treatment
𝑉𝑒𝑡𝐶𝑀 = 𝑁𝐶𝑀 × 𝐹𝑉𝑒𝑡𝐶𝑀 × 𝑃𝑉𝑒𝑡𝐶𝑀
In which FVetCM is the fraction of cows with CM which require veterinary visit and PvetCM is the price of 
a veterinary visit.
Costs of discarded milk
𝐷𝑀𝐶𝑀 = 𝑁𝐶𝑀𝐴𝐵 × 𝑀𝑃𝑑𝑎𝑦 × [𝑃𝑚𝑖𝑙𝑘 + 𝑃𝑓𝑒𝑒𝑑] × 𝐷𝐷𝑀𝐶𝑀𝑑𝑖𝑠𝑐𝑎𝑟𝑑
In which MPday is the average milk production per cow (kg milk/cow/day) and DDMCMdiscard is the 
withdrawal period in days.
Costs of alternative treatments
𝐴𝑙𝑡𝑇𝐶𝑀 = 𝑁𝐴𝑙𝑡𝑇𝐶𝑀 × 𝑃𝐴𝑙𝑡𝑇𝐶𝑀
In which NAltTCM is the number of cows with CM receiving alternative treatment and PAltTCM the price of 
one full treatment.
Costs of labour
𝐿𝑎𝑏𝑜𝑢𝑟𝐶𝑀 = 𝑁𝐶𝑀 × [𝑇𝑟𝑡𝑇𝑖𝑚𝑒𝐶𝑀/60] × 𝑃𝐿𝑎𝑏𝑜𝑢𝑟
In which TrtTimeCM is the treatment time (minutes) a farmer has to spend on one case of CM and 
Plabour is the costs of labour (€/hr)
Costs of herd removal
𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐶𝑀 = 𝑁𝑐𝑢𝑙𝐶𝑀 × [𝑃𝑟𝑒𝑝 ‒ 𝑃𝑠𝑙𝑣] + 𝑁𝑑𝑒𝑠𝐶𝑀 × [𝑃𝑟𝑒𝑝 + 𝑃𝑠𝑙𝑣]
In which NculCM is the number of cows voluntarily culled for mastitis reasons, NdesCM is the number of 
dairy cows that died on the farm and subsequently destructed as a consequence of mastitis, Prep is 
the replacement value of an average dairy cow (€/cow) and Pslv is the slaughter value for an average 
dairy cow (€/cow).
Total Costs of mastitis
𝐶𝑚𝑎𝑠𝑡𝑖𝑡𝑖𝑠 = 𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝑀 + 𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝑀 + 𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐶𝑀 + 𝑉𝑒𝑡𝐶𝑀 + 𝐷𝑀𝐶𝑀 + 𝐴𝑙𝑡𝑇𝐶𝑀 + 𝐿𝑎𝑏𝑜𝑢𝑟𝐶𝑀+ 𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐶𝑀
Lameness
Costs are presented on herd level. Costs categories are the same as presented above for mastitis but 
now directed to lameness (indicated by L). Only deviating input variables are described in more 
detail.
Milk production loss lameness
𝑀𝑃𝑙𝑜𝑠𝑠𝐿 = [𝑁𝐿1 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐿1 +  𝑁𝐿2 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐿2 + 𝑁𝐿3 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐿3]× [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
In which NL1 is the number of cows with lameness category 1, NL2 is the number of cows with 
lameness category 2 and NL3 is the number of cows with lameness category 3.
Costs of discarded milk
 𝐷𝑀𝐿 = 𝑁𝐿𝐴𝐵 × 𝑀𝑃𝑑𝑎𝑦 × [𝑃𝑚𝑖𝑙𝑘 + 𝑃𝑓𝑒𝑒𝑑] × 𝐷𝐷𝑀𝐿𝑑𝑖𝑠𝑐𝑎𝑟𝑑
Costs of medication
𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐿 = [𝑁𝐿𝐴𝐵 + 𝑁𝐿𝑁𝐴𝐵] × 𝑃𝑚𝑒𝑑𝐿
Costs of veterinarian
𝑉𝑒𝑡𝐿 = 𝑁𝐿3 × 𝐹𝑉𝑒𝑡𝐿 × 𝑃𝑉𝑒𝑡𝐿
Costs of alternative therapy
𝐴𝑙𝑡𝑇𝐿 = 𝑁𝐴𝑙𝑡𝑇𝐿 × 𝑃𝐴𝑙𝑡𝑇𝐿
Costs of labour
𝐿𝑎𝑏𝑜𝑢𝑟𝐿 = 𝑁𝐿3 × [𝑇𝑟𝑡𝑇𝑖𝑚𝑒𝐿/60] × 𝑃𝐿𝑎𝑏𝑜𝑢𝑟
Costs of herd removal
𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐿 = 𝑁𝑐𝑢𝑙𝐿 × [𝑃𝑟𝑒𝑝 ‒ 𝑃𝑠𝑙𝑣] + 𝑁𝑑𝑒𝑠𝐿 × [𝑃𝑟𝑒𝑝 + 𝑃𝑠𝑙𝑣]
Total Costs of lameness
𝐶𝑙𝑎𝑚𝑒𝑛𝑒𝑠𝑠 = 𝑀𝑃𝑙𝑜𝑠𝑠𝐿 + 𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐿 + 𝑉𝑒𝑡𝐿 + 𝐷𝑀𝐿 + 𝐴𝑙𝑡𝑇𝐿 + 𝐿𝑎𝑏𝑜𝑢𝑟𝐿 + 𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐿
Costs of ketosis
Costs are presented on herd level. Costs categories are the same as presented above for mastitis but 
now directed to ketosis (indicated by SCK for subclinical ketosis and by CK for clinical ketosis). Only 
deviating input variable are described in more detail.
Milk production loss subclinical ketosis
𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐾 = 𝑁𝑆𝐶𝐾 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐾 × [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
Milk production loss clinical ketosis
𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝐾 = 𝑁𝐶𝐾 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝐾 × [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
Costs of discarded milk
𝐷𝑀𝐶𝐾 = 𝑁𝐶𝐾𝐴𝐵 × 𝑀𝑃𝑑𝑎𝑦 × [𝑃𝑚𝑖𝑙𝑘 + 𝑃𝑓𝑒𝑒𝑑] × 𝐷𝐷𝑀𝐶𝐾𝑑𝑖𝑠𝑐𝑎𝑟𝑑
Costs of medication
𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐶𝐾 = [𝑁𝐶𝐾𝐴𝐵 + 𝑁𝐶𝐾𝑁𝐴𝐵] × 𝑃𝑚𝑒𝑑𝐶𝐾
Costs of alternative therapy
𝐴𝑙𝑡𝑇𝐶𝐾 = 𝑁𝐶𝐾 × 0.5 × 𝑃𝐴𝑙𝑡𝑇𝐿
Costs of veterinarian
𝑉𝑒𝑡𝐶𝐾 = 𝑁𝐶𝐾 × 𝐹𝑉𝑒𝑡𝐶𝐾 × 𝑃𝑉𝑒𝑡𝐶𝐾
Costs of labour
𝐿𝑎𝑏𝑜𝑢𝑟𝐶𝐾 = 𝑁𝐶𝐾 × [𝑇𝑟𝑡𝑇𝑖𝑚𝑒𝐶𝐾/60] × 𝑃𝐿𝑎𝑏𝑜𝑢𝑟
Costs of herd removal
𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐶𝐾 = 𝑁𝑐𝑢𝑙𝐶𝐾 × [𝑃𝑟𝑒𝑝 ‒ 𝑃𝑠𝑙𝑣] + 𝑁𝑑𝑒𝑠𝐶𝐾 × [𝑃𝑟𝑒𝑝 + 𝑃𝑠𝑙𝑣]
Total Costs of ketosis
𝐶𝑘𝑒𝑡𝑜𝑠𝑖𝑠 = 𝑀𝑃𝑙𝑜𝑠𝑠𝑆𝐶𝐾 + 𝑀𝑃𝑙𝑜𝑠𝑠𝐶𝐾 + 𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐶𝐾 + 𝑉𝑒𝑡𝐶𝐾 + 𝐷𝑀𝐶𝐾 + 𝐴𝑙𝑡𝑇𝐶𝐾 + 𝐿𝑎𝑏𝑜𝑢𝑟𝐶𝐾+ 𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐶𝐾
Costs of metritis
Costs are presented on herd level. Costs categories are the same as presented above for mastitis but 
now directed to ketosis (indicated by EM for early metritis and by LM for late metritis). Only 
deviating input variables are described in more detail.
Milk production loss early metritis
𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀 = [𝑁𝐸𝑀 × 𝐹𝑃1 × 𝑀𝑃𝑦𝑟 × 𝑀𝑃𝑐𝑜𝑟𝑟𝑃1 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀𝑃1]+ [𝑁𝐸𝑀 × 𝐹𝑃2 × 𝑀𝑃𝑦𝑟 × 𝑀𝑃𝑐𝑜𝑟𝑟𝑃2 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀𝑃2] +  [𝑁𝐸𝑀 × 𝐹𝑃3 × 𝑀𝑃𝑦𝑟 × 𝑀𝑃
𝑐𝑜𝑟𝑟𝑃3 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀𝑃3] +  [𝑁𝐸𝑀 × 𝐹 ≥ 𝑃4 × 𝑀𝑃𝑦𝑟 × 𝑀𝑃𝑐𝑜𝑟𝑟 ≥ 𝑃4 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀 ≥ 𝑃4]× [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
In which FP1 is the fraction of dairy cows in parity 1, FP2 is the fraction of cows in parity 2, MPcorrP1 is 
the correction factor for milk production for parity 1 cows, MPcorrP2 is the correction factor for milk 
production for parity 2 cows
Milk production loss late metritis
𝑀𝑃𝑙𝑜𝑠𝑠𝐿𝑀 = 𝑁𝐿𝑀 × 𝑀𝑃𝑦𝑟 × 𝑃𝑀𝑃𝑙𝑜𝑠𝑠𝐿𝑀 × [𝑃𝑚𝑖𝑙𝑘 ‒ 𝑃𝑓𝑒𝑒𝑑]
Costs of discarded milk
𝐷𝑀𝐸𝑀𝐿𝑀 = 𝑁𝐸𝑀𝐿𝑀𝐴𝐵 × 𝑀𝑃𝑑𝑎𝑦 × [𝑃𝑚𝑖𝑙𝑘 + 𝑃𝑓𝑒𝑒𝑑] × 𝐷𝐷𝑀𝐸𝑀𝐿𝑀𝑑𝑖𝑠𝑐𝑎𝑟𝑑
Costs of labour
𝐿𝑎𝑏𝑜𝑢𝑟𝐸𝑀𝐿𝑀 = [𝑁𝐸𝑀 × [𝑇𝑟𝑡𝑇𝑖𝑚𝑒𝐸𝑀/60] × 𝑃𝐿𝑎𝑏𝑜𝑢𝑟] + [𝑁𝐿𝑀 × [𝑇𝑟𝑡𝑇𝑖𝑚𝑒𝐿𝑀/60] × 𝑃𝐿𝑎𝑏𝑜𝑢𝑟]
Costs of herd removal
𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐸𝑀𝐿𝑀 = 𝑁𝑐𝑢𝑙𝐸𝑀𝐿𝑀 × [𝑃𝑟𝑒𝑝 ‒ 𝑃𝑠𝑙𝑣] + 𝑁𝑑𝑒𝑠𝐸𝑀𝐿𝑀 × [𝑃𝑟𝑒𝑝 + 𝑃𝑠𝑙𝑣]
Costs of veterinarian
𝑉𝑒𝑡𝐸𝑀𝐿𝑀 = 𝑁𝐸𝑀𝐿𝑀 × 𝐹𝑉𝑒𝑡𝐸𝑀𝐿𝑀 × 𝑃𝑉𝑒𝑡𝐸𝑀𝐿𝑀
Costs of medication
𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐸𝑀𝐿𝑀 = [𝑁𝐸𝑀𝐿𝑀𝐴𝐵 + 𝑁𝐸𝑀𝐿𝑀𝑁𝐴𝐵] × 𝑃𝑚𝑒𝑑𝐸𝑀𝐿𝑀
Costs of alternative therapy
𝐴𝑙𝑡𝑇𝐸𝑀𝐿𝑀 = 𝑁𝐸𝑀𝐿𝑀 × 0.5 × 𝑃𝐴𝑙𝑡𝑇𝐸𝑀𝐿𝑀
Total Costs of ketosis
𝐶𝑚𝑒𝑡𝑟𝑖𝑡𝑖𝑠 = 𝑀𝑃𝑙𝑜𝑠𝑠𝐸𝑀 + 𝑀𝑃𝑙𝑜𝑠𝑠𝐿𝑀 + 𝑀𝑒𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛𝐸𝑀𝐿𝑀 + 𝑉𝑒𝑡𝐸𝑀𝐿𝑀 + 𝐷𝑀𝐸𝑀𝐿𝑀 + 𝐴𝑙𝑡𝑇𝐸𝑀𝐿𝑀+ 𝐿𝑎𝑏𝑜𝑢𝑟𝐸𝑀𝐿𝑀 + 𝑅𝑒𝑚𝑜𝑣𝑎𝑙𝐸𝑀𝐿𝑀
